135 related articles for article (PubMed ID: 7840053)
21. Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure.
Montalescot G; Drobinski G; Meurin P; Maclouf J; Sotirov I; Philippe F; Choussat R; Morin E; Thomas D
Am J Cardiol; 1998 Sep; 82(6):749-55. PubMed ID: 9761085
[TBL] [Abstract][Full Text] [Related]
22. Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.
Stambler BS; Gottlieb SS; Singh BN; Ramanathan KB; Ogilby JD; Ellenbogen KA
J Am Coll Cardiol; 1995 Dec; 26(7):1679-84. PubMed ID: 7594103
[TBL] [Abstract][Full Text] [Related]
23. Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure.
Nanas JN; Kontoyannis DA; Alexopoulos GP; Anastasiou-Nana MI; Tsagalou EP; Stamatelopoulos SF; Moulopoulos SD
Chest; 2001 Apr; 119(4):1173-8. PubMed ID: 11296186
[TBL] [Abstract][Full Text] [Related]
24. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
McLaughlin VV; Genthner DE; Panella MM; Rich S
N Engl J Med; 1998 Jan; 338(5):273-7. PubMed ID: 9445406
[TBL] [Abstract][Full Text] [Related]
25. Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure.
Shah MR; Hasselblad V; Stinnett SS; Kramer JM; Grossman S; Gheorghiade M; Adams KF; Swedberg K; Califf RM; O'Connor CM
Eur J Heart Fail; 2002 Jun; 4(3):297-304. PubMed ID: 12034155
[TBL] [Abstract][Full Text] [Related]
26. The role of treprostinil in the management of pulmonary hypertension.
Skoro-Sajer N; Lang I
Am J Cardiovasc Drugs; 2008; 8(4):213-7. PubMed ID: 18690755
[TBL] [Abstract][Full Text] [Related]
27. One-year experience with intravenous treprostinil for pulmonary arterial hypertension.
Benza RL; Tapson VF; Gomberg-Maitland M; Poms A; Barst RJ; McLaughlin VV
J Heart Lung Transplant; 2013 Sep; 32(9):889-96. PubMed ID: 23953817
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E1 infusion compared with prostacyclin infusion in patients with refractory heart failure: effects on hemodynamics and neurohumoral variables.
Pacher R; Stanek B; Hülsmann M; Bojic A; Berger R; Frey B; Siegel A; Kos T; Ogris E; Grimm M; Laufer G
J Heart Lung Transplant; 1997 Aug; 16(8):878-81. PubMed ID: 9286780
[TBL] [Abstract][Full Text] [Related]
29. Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome.
Capomolla S; Febo O; Opasich C; Guazzotti G; Caporotondi A; La Rovere MT; Gnemmi M; Mortara A; Vona M; Pinna GD; Maestri R; Cobelli F
Eur J Heart Fail; 2001 Oct; 3(5):601-10. PubMed ID: 11595609
[TBL] [Abstract][Full Text] [Related]
30. Effects of intravenous milrinone followed by titration of high-dose oral vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failure.
Cusick DA; Pfeifer PB; Quigg RJ
Am J Cardiol; 1998 Nov; 82(9):1060-5. PubMed ID: 9817482
[TBL] [Abstract][Full Text] [Related]
31. Double-blind, placebo-controlled study of intravenous prostacyclin on hemodynamics in severe Raynaud's phenomenon: the acute vasodilatory effect is not sustained.
Kingma K; Wollersheim H; Thien T
J Cardiovasc Pharmacol; 1995 Sep; 26(3):388-93. PubMed ID: 8583779
[TBL] [Abstract][Full Text] [Related]
32. Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans.
Sütsch G; Bertel O; Kiowski W
Cardiovasc Drugs Ther; 1997 Jan; 10(6):717-25. PubMed ID: 9110115
[TBL] [Abstract][Full Text] [Related]
33. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.
Cabrol S; Souza R; Jais X; Fadel E; Ali RH; Humbert M; Dartevelle P; Simonneau G; Sitbon O
J Heart Lung Transplant; 2007 Apr; 26(4):357-62. PubMed ID: 17403477
[TBL] [Abstract][Full Text] [Related]
34. Bolus versus continuous low dose of enalaprilat in congestive heart failure with acute refractory decompensation.
Podbregar M; Voga G; Horvat M; Zuran I; Krivec B; Skale R; Pareznik R
Cardiology; 1999; 91(1):41-9. PubMed ID: 10393397
[TBL] [Abstract][Full Text] [Related]
35. Tolerability of extended duration intravenous milrinone in patients hospitalized for advanced heart failure and the usefulness of uptitration of oral angiotensin-converting enzyme inhibitors.
Milfred-LaForest SK; Shubert J; Mendoza B; Flores I; Eisen HJ; Piña IL
Am J Cardiol; 1999 Oct; 84(8):894-9. PubMed ID: 10532506
[TBL] [Abstract][Full Text] [Related]
36. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
37. [Ten years' experience in continuous intravenous epoprostenol therapy in severe pulmonary arterial hypertension].
Pombo Jiménez M; Escribano Subías P; Tello de Meneses R; Gómez-Sánchez MA; Delgado Jiménez J; Dalmau González-Gallarza R; Lázaro Salvador M; Hernández Rodríguez I; Tascón Pérez J; Sáenz de la Calzada C
Rev Esp Cardiol; 2003 Mar; 56(3):230-5. PubMed ID: 12622952
[TBL] [Abstract][Full Text] [Related]
38. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
[TBL] [Abstract][Full Text] [Related]
39. Additive haemodynamic effects of piroximone and prostacyclin in severe chronic heart failure.
Albo C; Saal JP; Lellouche D; Habbal R; Benvenuti C; Deleuze P; Loisance D; Castaigne A; Dubois-Randé JL
Eur Heart J; 1994 Apr; 15(4):528-33. PubMed ID: 8070481
[TBL] [Abstract][Full Text] [Related]
40. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
